Literature DB >> 16331333

Control of methicillin-resistant Staphylococcus aureus in the UK.

I M Gould1.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) continues to evolve. Thus far, efforts to control the spread of MRSA in the UK have failed, resulting in a great deal of public and political concern. New guidelines advocate a much more active "seek and destroy" policy, but the causes of the epidemic go back 30 years to the start of an extended period of disinvestment in the national health service. Consequently, a multifaceted approach is needed now, one that includes a huge investment in infrastructure and facilities for patient isolation, cleaning and disinfection of equipment, laboratory diagnosis of MRSA, antibiotic stewardship, and training of medical and nursing staff.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16331333     DOI: 10.1007/s10096-005-0060-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination.

Authors:  G L French; J A Otter; K P Shannon; N M T Adams; D Watling; M J Parks
Journal:  J Hosp Infect       Date:  2004-05       Impact factor: 3.926

Review 2.  Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature.

Authors:  B S Cooper; S P Stone; C C Kibbler; B D Cookson; J A Roberts; G F Medley; G Duckworth; R Lai; S Ebrahim
Journal:  BMJ       Date:  2004-09-04

3.  Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications.

Authors:  J M Boyce; G Potter-Bynoe; C Chenevert; T King
Journal:  Infect Control Hosp Epidemiol       Date:  1997-09       Impact factor: 3.254

4.  Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis.

Authors:  M Whitby; M L McLaws; G Berry
Journal:  Med J Aust       Date:  2001-09-03       Impact factor: 7.738

5.  The stethoscope. A potential source of nosocomial infection?

Authors:  M A Marinella; C Pierson; C Chenoweth
Journal:  Arch Intern Med       Date:  1997-04-14

6.  Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA.

Authors:  Angelo Pan; Giuseppe Carnevale; Patrizia Catenazzi; Paolo Colombini; Luciano Crema; Lucia Dolcetti; Lucio Ferrari; Placido Mondello; Liana Signorini; Carmine Tinelli; Eugenia Quiros Roldan; Giampiero Carosi
Journal:  Infect Control Hosp Epidemiol       Date:  2005-02       Impact factor: 3.254

7.  High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies.

Authors:  Jean-Christophe Lucet; Karine Grenet; Laurence Armand-Lefevre; Marion Harnal; Elisabeth Bouvet; Bernard Regnier; Antoine Andremont
Journal:  Infect Control Hosp Epidemiol       Date:  2005-02       Impact factor: 3.254

8.  New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci.

Authors:  A Huletsky; R Giroux; V Rossbach; M Gagnon; M Vaillancourt; M Bernier; F Gagnon; K Truchon; M Bastien; F J Picard; A van Belkum; M Ouellette; P H Roy; M G Bergeron
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.

Authors:  Sara E Cosgrove; George Sakoulas; Eli N Perencevich; Mitchell J Schwaber; Adolf W Karchmer; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2002-12-13       Impact factor: 9.079

10.  Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000.

Authors:  Dominique L Monnet; Fiona M MacKenzie; José Maria López-Lozano; Arielle Beyaert; Máximo Camacho; Rachel Wilson; David Stuart; Ian M Gould
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more
  4 in total

1.  Are healthcare economics a factor behind European MRSA rates?

Authors:  M A Borg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-30       Impact factor: 3.267

Review 2.  The management of infections due to drug-resistant gram-positive bacteria.

Authors:  R C Moellering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

3.  Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum beta-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study.

Authors:  X Bertrand; L Mouchot; M Jebabli; O Bajolet; S Aho; M-F Blech; C Eloy; N Floret; S Gayet; D Talon; H Tronel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

4.  An observational prospective study of topical acidified nitrite for killing methicillin-resistant Staphylococcus aureus (MRSA) in contaminated wounds.

Authors:  Anthony D Ormerod; Amjad Aj Shah; Hong Li; Nigel B Benjamin; Gail P Ferguson; Carlo Leifert
Journal:  BMC Res Notes       Date:  2011-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.